Fosun Pharmaceutical (Group) Co. acquired 60% stake of Foshan City Chanchen Hospital with RMB 693 million. Based on the agreement, the Chanchen Hospital shall ensure that revenue from 2013-2015 reach RMB 90 million, 108 million and 129 million, respectively.

Fusun pharma maintains its core business pharmaceutical section's investment, in the meantime, also enhance its another strategic segment healthcare service competence. It is also a trend reflected by Gansu Duyiwei, Kangmei Pharma that traditional pharmaceutical companies are turning their attention on the real hospital operations.